| B. subtilis | Bacillus subtilis |
| CAT | Acatalase |
| 3-CA | 3-Chloroaniline |
| 4-CA | 4-Chloroaniline |
| CFDA | Carboxyfluorescein diacetate |
| CEC | Contaminant of Emerging Concern |
| C. elegans | Caenorhabditis elegans |
| 3,4-DCA | 3,4-Dichloroaniline |
| DCC | 4,4′-Dichlorocarbanilide |
| DHC | 3′,4′-Dichloro-4-hydroxycarbanilide |
| E. coli | Escherichia coli |
| E. faecalis | Enterococcus faecalis |
| EOCs | Emerging Organic Contaminants |
| ERRγ | Estrogen-related receptor γ |
| EU | European Union |
| FDA | Food and Drug Administration |
| GJIC | Gap junctional intercellular communication |
| GSH | Glutathione |
| GST | GLUTATHIONE-S-TRANSFERASE |
| IE | INFECTIVE ENDOCARDITIS |
| LPO | LIPID PEROXIDATION |
| MCC | 1-(3-Chlorophenyl)-3-phenylurea |
| MICs | Minimum inhibitory concentrations |
| NCC | Carbanilide |
| NIS | Sodium/iodide symporter |
| NRU | Neutral red uptake |
| 2′-OH-TCC | 2′-Hydroxytriclocarban |
| 3′-OH-TCC | 3′-Hydroxytriclocarban |
| P. aeruginosa | Pseudomonas aeruginosa |
| P. falciparum | Plasmodium falciparum |
| P. mirabilis | Proteus mirabilis |
| PPCPs | Personal care product compounds |
| S. aureus | Staphylococcus aureus |
| S. epidermidis | Staphylococcus epidermidis |
| S. japonicum | Schistosoma japonicum |
| S. mansoni | Schistosoma mansoni |
| sEH | Soluble epoxide hydrolase |
| TCC | Triclocarban |
| TCS | Triclosan |
| TH | Thyroid hormone |
| Tjp1 | Tight junction protein 1 |
| TPO | Thyroid peroxidase |
| TRVP1 | Transient receptor potential vanilloid 1 |
| UGTs | UDP-glucuronosyltransferases |
| U.S. | United States |
| WRRF | Water resource recovery facility |
| WWT | Wastewater treatment |
| WWTPs | Wastewater treatment plants |